Templated open flocs of nanorods for enhanced pulmonary delivery with pressurized metered dose inhalers

Pharmaceutical Research

Volumn 26, Issue 1, 2009, Pages 101-117

  Engstrom, Josh D ^a   Tam, Jasmine M ^a   Miller, Maria A ^a   Williams III, Robert O ^b   Johnston, Keith P ^a  

^a The University of Texas at Austin   (United States)

^b UNIVERSITY OF TEXAS AT AUSTIN   (United States)

Author keywords

Bovine serum albumin; Floc; Nanorod; Pressurized metered dose inhaler; Suspension stability

Indexed keywords

APAFLURANE; BOVINE SERUM ALBUMIN; FLUORINATED HYDROCARBON; NANOROD; PERFLUOROPENTANE; PROPELLANT;

AEROSOL; ARTICLE; DRUG DELIVERY SYSTEM; DRUG FORMULATION; FLOCCULATION; FREEZE DRYING; LUNG; METERED DOSE INHALER; PARTICLE SIZE; PRIORITY JOURNAL;

ACETONITRILES; ALGORITHMS; CHLOROFLUOROCARBONS, METHANE; DRUG DELIVERY SYSTEMS; HYDROCARBONS, FLUORINATED; LIGHT; LUNG; NANOTUBES; NEBULIZERS AND VAPORIZERS; PARTICLE SIZE; SCATTERING, RADIATION; SERUM ALBUMIN, BOVINE; SUSPENSIONS;

EID: 57749181307     PISSN: 07248741     EISSN: 1573904X     Source Type: Journal    
DOI: 10.1007/s11095-008-9707-z     Document Type: Article

References (76)

1. R. U. Agu M. I. Ugwoke M. Armand R. Kinget N. Verbeke 2001 The lung as a route for systemic delivery of therapeutic proteins and peptides Respir. Res. 2 198 209
2. A. L. Adjei P. K. Gupta 1997 Inhalation delivery of therapeutic peptides and proteins Int. J. Pharm. 159 259
3. S. White D. B. Bennett S. Cheu P. W. Conley D. B. Guzek S. Gray J. Howard R. Malcolmson J. M. Parker P. Roberts N. Sadrzadeh J. D. Schumacher S. Seshadri G. W. Sluggett C. L. Stevenson N. J. Harper 2005 EXUBERA: pharmaceutical development of a novel product for pulmonary delivery of insulin Diabetes Technol. Ther. 7 896 906
4. S. A. Shoyele A. Slowey 2006 Prospects of formulating proteins/peptides as aerosols for pulmonary drug delivery Int. J. Pharm. 314 1 8
5. H. M. Courrier N. Butz T. F. Vandamme 2002 Pulmonary drug delivery systems: recent developments and prospects Crit. Rev. Ther. Drug Carr. Syst. 19 425 498
6. M. J. Kwon J. H. Bae J. J. Kim K. Na E. S. Lee 2007 Long acting porous microparticle for pulmonary protein delivery Int. J. Pharm. 333 5 9
7. J. S. Patton P. R. Byron 2007 Inhaling medicines: delivering drugs to the body through the lungs Nature Reviews Drug Discovery 6 67 74
8. V. Codrons F. Vanderbist R. K. Verbeeck M. Arras D. Lison V. Preat R. Vanbever 2003 Systemic delivery of parathyroid hormone (1-34) using inhalation dry powders in rats J. Pharm. Sci. 92 938 950
9. L. Garcia-Contreras H. D. C. Smyth 2005 Liquid-spray or dry-powder systems for inhaled delivery of peptide and proteins? American Journal of Drug Delivery 3 29 45
10. D. Traini P. Young P. Rogueda R. Price 2006 The use of AFM and surface energy measurements to investigate drug-canister material interactions in a model pressurized metered dose inhaler formulation Aerosol Sci. Tech. 40 227 236
11. P. Rogueda 2005 Novel hydrofluoroalkane suspension formulations for respiratory drug delivery Expert Opinion on Drug Delivery 2 625 638
12. R. O. Williams III J. Liu 1999 Formulation of a protein with propellant HFA 134a for aerosol delivery Eur. J. Pharm. Sci. 7 137 144
13. R. O. Williams III M. Repka J. Liu 1998 Influence of propellant composition on drug delivery from a pressurized metered-dose inhaler Drug Dev. Ind. Pharm. 24 763 770
14. K. A. Johnson. Interfacial phenomena and phase behavior in metered dose inhaler formulations. In A. J. Hickey (ed.), Inhalation Aerosols: Physical and Biological Basis for Therapy, Vol. 221. Lung Biology in Health and Disease, 2007.
15. E. A. Quinn R. T. Forbes A. C. Williams M. J. Oliver L. McKenzie T. S. Purewal 1999 Protein conformational stability in the hydrofluoroalkane propellants tetrafluoroethane and heptafluoropropane analyzed by Fourier transform Raman spectroscopy Int. J. Pharm. 186 31 41
16. M. J. Oliver, L. McKenzie, W. D. Graffiths, G. R. Morgan, and N. O'Kelly. Initial assessment of a protein formulated in pressurized MDIS for pulmonary delivery. In RDD VII, 2000.
17. C. Benfait. Kos reports achievement of new research and development milestones. Kos Press Release (2004).
18. J. Heyder J. Gebhart G. Rudolf C. F. Schiller W. Stahlhofen 1986 Deposition of particles in the human respiratory tract in the size range 0.005-15 μm J. Aerosol Sci. 17 811 825
19. A. Ben-Jebria D. Chen M. L. Eskew R. Vanbever R. Langer D. A. Edwards 1999 Large porous particles for sustained protection from carbachol-induced bronchoconstriction in guinea pigs Pharm. Res. 16 555 561
20. N. Tsapis D. Bennett B. Jackson D. A. Weitz D. A. Edwards 2002 Trojan particles: large porous carriers of nanoparticles for drug delivery Proc. Natl. Acad. Sci. U. S. A. 99 12001 12005
21. L. A. Dellamary T. E. Tarara D. J. Smith C. H. Woelk A. Adractas M. L. Costello H. Gill J. G. Weers 2000 Hollow porous particles in metered dose inhalers Pharm. Res. 17 168 174
22. Y.-F. Maa P.-A. Nguyen T. Sweeney S. J. Shire C. C. Hsu 1999 Protein inhalation powders: spray drying vs spray freeze drying Pharm. Res. 16 249 254
23. Y.-F. Maa, and H. R. Costantino. Spray freeze-drying of biopharmaceuticals: applications and stability considerations. In H. R. Costantino, and M. J. Pikal (eds.), Biotechnology: Pharmaceutical Aspects. 2. Lyophilization of Biopharmaceuticals, Vol. 2, American Association of Pharmaceutical Scientists, Arlington, 2004, pp. 519-561.
24. Z. Yu A. S. Garcia K. P. Johnston R. O. Williams III 2004 Spray freezing into liquid nitrogen for highly stable protein nanostructured microparticles Eur. J. Pharm. Biopharm. 58 529 537
25. J. D. Engstrom D. T. Simpson E. Lai R. O. Williams III K. P. Johnston 2007 Morphology of protein particles produced by spray freezing of concentrated solutions Eur. J. Pharm. Biopharm. 65 149 162
26. J. D. Engstrom D. T. Simpson C. Cloonan E. Lai R. O. Williams III G. B. Kitto K. P. Johnston 2007 Stable high surface area lactate dehydrogenase particles produced by spray freezing into liquid nitrogen Eur. J. Pharm. Biopharm. 65 163 174
27. Z. Yu K. P. Johnston R. O. Williams III 2006 Spray freezing into liquid versus spray-freeze drying: Influence of atomization on protein aggregation and biological activity Eur. J. Pharm. Sci. 27 9 18
28. Z. Yu T. L. Rogers J. Hu K. P. Johnston R. O. Williams III 2002 Preparation and characterization of microparticles containing peptide produced by a novel process: spray freezing into liquid Eur. J. Pharm. Biopharm. 54 221 228
29. J. D. Engstrom E. S. Lai B. Ludher B. Chen T. E. Milner G. B. Kitto R. O. Williams III K. P. Johnston 2008 Formation of stable submicron protein particles by thin film freezing Pharm. Res. 25 1334 1346
30. S. D. Webb S. L. Golledge J. L. Cleland J. F. Carpenter T. W. Randolph 2002 Surface adsorption of recombinant human interferon-γ in lyophilized and spray-lyophilized formulations J. Pharm. Sci. 91 1474 1487
31. X. C. Nguyen J. D. Herberger P. A. Burke 2004 Protein powders for encapsulation: a comparison of spray-freeze drying and spray drying of darbepoetin alfa Pharm. Res. 21 507 514
32. Y.-F. Maa S. J. Prestrelski 2000 Biopharmaceutical powders: particle formation and formulation considerations Curr. Pharm. Biotechnol. 1 283 302
33. I. Gonda 1985 Development of a systematic theory of suspension inhalation aerosols. I. A framework to study the effects of aggregation on the aerodynamic behavior of drug particles Int. J. Pharm. 27 99 116
34. Y.-H. Liao M. B. Brown S. A. Jones T. Nazir G. P. Martin 2005 The effects of polyvinyl alcohol on the in vitro stability and delivery of spray-dried protein particles from surfactant-free HFA 134a-based pressurised metered dose inhalers Int. J. Pharm. 304 29 39
35. M. Keller 1999 Innovations and perspectives of metered dose inhalers in pulmonary drug delivery Int. J. Pharm. 186 81 90
36. C. Vervaet P. R. Byron 1999 Drug-surfactant-propellant interactions in HFA-formulations Int. J. Pharm. 186 13 30
37. F. E. Blondino P. R. Byron 1998 Surfactant dissolution and water solubilization in chlorine-free liquified gas propellants Drug Dev. Ind. Pharm. 24 935 945
38. R. P. S. Peguin P. Selvam S. R. P. da Rocha 2006 Microscopic and thermodynamic properties of the HFA134a-water interface: atomistic computer simulations and tensiometry under pressure Langmuir 22 8826 8830
39. L. Wu, R. P. S. Peguin, P. Selvam, U. Chokshi, and S. R. P. da Rocha. Molecular scale behavior in alternative propellant-based inhaler formulations. In A. J. Hickey (ed), Inhalation Aerosols: Physical and biological basis for therapy, Vol. 221. Lung Biology in Health and Disease, 2007.
40. R. Vanbever J. D. Mintzes J. Wang J. Nice D. Chen R. Batycky R. Langer D. A. Edwards 1999 Formulation and physical characterization of large porous particles for inhalation Pharm. Res. 16 1735 1742
41. D. A. Edwards J. Hanes G. Caponetti J. Hrkach A. Ben-Jebria M. L. Eskew J. Mintzes D. Deaver N. Lotan R. Langer 1997 Large porous particles for pulmonary drug delivery Science 276 1868 1871
42. J. Tam, J. T. McConville, R. O. Williams III, and K. P. Johnston. Amorphous cyclosporin A nanodispersions for enhanced pulmonary deposition and dissolution. J. Pharm. Sci. in press (2008) doi: 10.1002/jps.21367.
43. Z. Jiang Y. Guan 2006 Flocculation morphology: effect of particulate shape and coagulant species on flocculation Water Sci. Technol. 53 9 16
44. I. Goodarz-Nia D. N. Sutherland 1975 Floc simulation. Effects of particle size and shape Chem. Eng. Sci. 30 407 12
45. P. C. Hiemenz and R. Rajagopalan. Principles of colloid and surface chemistry, Marcel Dekker, New York, 1997.
46. A. P. Philipse A. M. Wierenga 1998 On the density and structure formation in gels and clusters of colloidal rods and fibers Langmuir 14 49 54
47. A. P. Philipse 1996 The random contact equation and its implications for (colloidal) rods in packings, suspensions, and anisotropic powders Langmuir 12 5971
48. R. G. Larson. The structure and rheology of complex fluids. Oxford University Press, New York, 1999.
49. P. G. Smith Jr. W. Ryoo K. P. Johnston 2005 Electrostatically stabilized metal oxide particle dispersions in carbon dioxide J. Phys. Chem. B. 109 20155 20165
50. Y. Kim S. H. Atwell R. G. Bell 1992 Determination of water in pressurized pharmaceutical metered dose aerosol products Drug Dev. Ind. Pharm. 18 2185 2195
51. R. O. Williams III J. Liu J. J. Koleng 1997 Influence of metering chamber volume and water level on the emitted dose of a suspension-based pMDI containing propellant 134a Pharm. Res. 14 438 443
52. E. Berlin M. J. Pallansch 1968 Densities of several proteins and L-amino acids in the dry state J. Phys. Chem. 72 1887 1889
53. P. G. A. Rogueda 2003 HPFP, a model propellant for pMDIs Drug Dev. Ind. Pharm. 29 39 49
54. R. Ashayer P. F. Luckham S. Manimaaran P. Rogueda 2004 Investigation of the molecular interactions in a pMDI formulation by atomic force microscopy Eur. J. Pharm. Sci. 21 533 543
55. D. Traini M. Young Paul P. Rogueda R. Price 2007 In vitro investigation of drug particulates interactions and aerosol performance of pressurised metered dose inhalers Pharm. Res. 24 125 135
56. S. L. Nail, S. Jiang, S. Chongprasert, and S. A. Knopp. Fundamentals of freeze-drying. In S. L. Nailand, and M. J. Akers (eds.), Pharmaceutical Biotechnology. 14. Development and Manufacture of Protein Pharmaceuticals, Vol. 14, Kluwer, New York, 2002, pp. 281-360.
57. S. D. Webb J. L. Cleland J. F. Carpenter T. W. Randolph 2002 A new mechanism for decreasing aggregation of recombinant human interferon-g by a surfactant: slowed dissolution of lyophilized formulations in a solution containing 0.03% polysorbate 20 J. Pharm. Sci. 91 543 558
58. J. F. Carpenter, B. S. Chang, W. Garzon-Rodriguez, and T. W. Randolph. Rational design of stable lyophilized protein formulations: theory and practice. In J. F. Carpenter, and M. C. Manning (eds.), Pharmaceutical Biotechnology. 13. Rational Design of Stable Protein Formulations, Vol. 13, Kluwer, New York, 2002, pp. 109-133.
59. A. Farahnaky F. Badii I. A. Farhat J. R. Mitchell S. E. Hill 2005 Enthalpy relaxation of bovine serum albumin and implications for its storage in the glassy state Biopolymers 78 69 77
60. B. Y. Shekunov P. Chattopadhyay H. H. Y. Tong A. H. L. Chow 2007 Particle size analysis in pharmaceutics: principles, methods and applications Pharm. Res. 24 203 227
61. W. H. Finlay. The mechanics of inhaled pharmaceutical aerosols, Academic,New York, 2001.
62. A. Sihvola. Electromagnetic mixing formulas and applications, Institute of Electrical Engineers, London, 1999.
63. W. B. Russel, D. A. Saville, and W. R. Schowalter. Colloidal dispersions, Cambridge University Press, Cambridge, 1989.
64. D. Traini P. Rogueda P. Young R. Price 2005 Surface Energy and Interparticle Forces Correlations in Model pMDI Formulations Pharm. Res. 22 816 825
65. M. A. Bevan. Effect of adsorbed polymer on the interparticle potential, chemical engineering. Carnegie Mellon University, Pittsburgh, 1999.
66. P. Tang J. Greenwood J. A. Raper 2002 A model to describe the settling behavior of fractal aggregates J. Colloid Interface Sci. 247 210 219
67. C. Fargues C. Turchiuli 2004 Structural characterization of flocs in relation to their settling performances Chem. Eng. Res. Des. 82 1517
68. H. Abramowitz P. S. Shah P. F. Green K. P. Johnston 2004 Welding colloidal crystals with carbon dioxide Macromolecules 37 7316 7324
69. D. R. Ulrich 1990 Chemical processing of ceramics Chem. Eng. News 68 28 40
70. H. D. C. Smyth, A. J. Hickey, and R. M. Evans. Aerosol generation from propellant-driven metered dose inhalers. In J. Hickey Anthony (ed), Inhalation Aerosols: Physical and Biological Basis for Therapy, Vol. 221, Lung biology in health and disease, 2007, pp. 399-416.
71. D. L. French D. A. Edwards R. W. Niven 1996 The influence of formulation on emission, deaggregation and deposition of dry powders for inhalation J. Aerosol Sci. 27 769 783
72. T. L. Rogers A. C. Nelsen J. Hu J. N. Brown M. Sarkari T. J. Young K. P. Johnston R. O. Williams III 2002 A novel particle engineering technology to enhance dissolution of poorly water soluble drugs: spray-freezing into liquid Eur. J. Pharm. Biopharm. 54 271 280
73. T. L. Rogers K. A. Overhoff P. Shah P. Santiago M. J. Yacaman K. P. Johnston R. O. Williams III 2003 Micronized powders of a poorly water soluble drug produced by a spray-freezing into liquid-emulsion process Eur. J. Pharm. Biopharm. 55 161 72
74. J. Israelachvili. Intermolecular and surface forces. Academic, San Diego, 1992.
75. S. Takashima 1965 Proton fluctuation in protein. Experimental study of the Kirkwood-Shumaker theory J. Phys. Chem. 69 2281 2286
76. R. Tadmor 2001 The London-van der Waals interaction energy between objects of various geometries J. Phys. Condens. Matter 13 L195 L202